Atlas Trials

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

Clinical trial NCT06054035 · RECRUITING

Trial details

NCT number
NCT06054035
Sponsor
University Hospital Tuebingen
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Type2diabetesPreDiabetesRenal Failure
Start date
2023-10-26
Primary completion
2027-06-30
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.